
### [MONDO:0017734](http://purl.obolibrary.org/obo/MONDO_0017734)
**Label:** sialidosis

**Subclasses:** [MONDO:0009738](http://purl.obolibrary.org/obo/MONDO_0009738) (sialidosis type 2), [MONDO:0019346](http://purl.obolibrary.org/obo/MONDO_0019346) (sialidosis type 1), [MONDO:0009730](http://purl.obolibrary.org/obo/MONDO_0009730) (Nephrosialidosis), [MONDO:0019681](http://purl.obolibrary.org/obo/MONDO_0019681) (juvenile sialidosis type 2), [MONDO:0019682](http://purl.obolibrary.org/obo/MONDO_0019682) (congenital sialidosis type 2), 

**Corr. equiv. classes:** [Orphanet:812](http://www.orpha.net/ORDO/Orphanet_812), [Orphanet:87876](http://www.orpha.net/ORDO/Orphanet_87876), [OMIM:256150](http://purl.obolibrary.org/obo/OMIM_256150), [Orphanet:93400](http://www.orpha.net/ORDO/Orphanet_93400), [OMIM:256550](http://purl.obolibrary.org/obo/OMIM_256550), [Orphanet:93399](http://www.orpha.net/ORDO/Orphanet_93399), 

**Class expressions from DL-Learner:**

- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:3000036](http://purl.obolibrary.org/obo/HP_3000036) (Abnormality of head blood vessel) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0100790](http://purl.obolibrary.org/obo/HP_0100790) (Hernia) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0012061](http://purl.obolibrary.org/obo/HP_0012061) (Urinary excretion of sialylated oligosaccharides) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0011443](http://purl.obolibrary.org/obo/HP_0011443) (Abnormality of coordination) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0011283](http://purl.obolibrary.org/obo/HP_0011283) (Abnormality of the metencephalon) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0011282](http://purl.obolibrary.org/obo/HP_0011282) (Abnormality of hindbrain morphology) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0011004](http://purl.obolibrary.org/obo/HP_0011004) (Abnormal systemic arterial morphology) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0010729](http://purl.obolibrary.org/obo/HP_0010729) (Cherry red spot of the macula) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0010471](http://purl.obolibrary.org/obo/HP_0010471) (Oligosacchariduria) 66.67%
- [HP:0003461](http://purl.obolibrary.org/obo/HP_0003461) (Increased urinary O-linked sialopeptides) and [HP:0008047](http://purl.obolibrary.org/obo/HP_0008047) (Abnormality of the vasculature of the eye) 66.67%


